EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Total Synthesis of the Marine Cyclic Depsipeptide Lagunamide D

Huiru Nan, Xiong-En Long, Jianfei He, Hailiang Xing, Min-Jing Cheng iD, Jin-Bao Peng, Tao Ye iD, Jia-Lei Yan iD, Junyang Liu iD

Marine Drugs · 2025

DOI: 10.3390/md23030099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Huiru Nan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Food Engineering, Wuyi University, Jiangmen 529020, China. Hauptthemen laut MEDLINE: Depsipeptides, Cyanobacteria, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Department of Education of Guangdong Province, Department of Education of Guangdong Province, Technology and Innovation Bureau of Longgang District.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lagunamide D is a structurally distinct 26-membered cytotoxic cyclic depsipeptide, originally isolated from a marine cyanobacterium. It exhibits potent antiproliferative activity in the low nanomolar range against A549 human lung adenocarcinoma cells and HCT116 colon cancer cells. A significant challenge associated with lagunamide D is its propensity for intramolecular acyl migration, which leads to the formation of a contracted 24-membered analog, lagunamide D′. This structural rearrangement complicates its isolation, characterization, and synthesis. In this study, the total synthesis of lagunamide D was achieved in a 14-step longest linear sequence, starting from the known intermediate 17, with an overall yield of 4.6%. The synthetic strategy involved several key transformations, including Ghosh’s TiCl4-promoted anti-aldol reaction, Corey–Bakshi–Shibata reduction (CBS reduction), cross-metathesis, Pinnick oxidation, and Yamaguchi esterification. Furthermore, this synthetic effort unambiguously confirmed the stereochemistry of the natural product.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DepsipeptidesCyanobacteriaAntineoplastic AgentsHumansAquatic OrganismsCell Line, TumorHCT116 Cells

Stichwörter der Autor:innen

depsipeptidelagunamide Dmarine natural productstotal synthesis

Substanzen

DepsipeptidesAntineoplastic Agents

Autor:innen und Institutionen

  • School of Pharmacy and Food Engineering, Wuyi University, Jiangmen 529020, China.
  • Center for Bioactive Natural Molecules and Innovative Drugs, and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632,…
  • State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.
  • Qian Yan (Shenzhen) Pharmatech. Ltd., Shenzhen 518172, China.

ORCID-Profile: Min-Jing Cheng, Tao Ye, Jia-Lei Yan, Junyang Liu

Förderung

  • the Department of Education of Guangdong Province
  • Department of Education of Guangdong Province
  • Technology and Innovation Bureau of Longgang District
  • Guangdong Basic and Applied Basic Research Foundation
  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China
  • Jiangmen Basic and Applied Basic Research Project

Zitieren

APA

Nan, H., Long, X. E., He, J., Xing, H., Cheng, M. J., Peng, J. B., Ye, T., Yan, J. L., & Liu, J. (2025). Total Synthesis of the Marine Cyclic Depsipeptide Lagunamide D. Marine Drugs. https://doi.org/10.3390/md23030099

Vancouver

Nan H, Long XE, He J, Xing H, Cheng MJ, Peng JB, et al. Total Synthesis of the Marine Cyclic Depsipeptide Lagunamide D. Marine Drugs. 2025. doi:10.3390/md23030099

BibTeX
@article{Nan2025,
  author = {Nan, Huiru and Long, Xiong-En and He, Jianfei and Xing, Hailiang and Cheng, Min-Jing and Peng, Jin-Bao and Ye, Tao and Yan, Jia-Lei and Liu, Junyang},
  title = {Total Synthesis of the Marine Cyclic Depsipeptide Lagunamide D},
  journal = {Marine Drugs},
  year = {2025},
  doi = {10.3390/md23030099}
}
Kostenlos starten →